Directory · IL
Pharmaceutical Manufacturing in Israel
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Israel. Browse the public index, then filter or export on Kipplo.
Companies
236 on file
Cts Ltd
CTS Ltd is one of the most prominent companies in Israel engaged in healthcare and agriculture. For more than 100 years our goal has been to improve health and quality of life by providing our customers with innovative and excellent products. For that purpose we collaborate with leading international pharmaceutical companies as well as manufacture our own Rx, OTC, Medical Device and food supplements products in our manufacturing, state of the art, plants. Presently, CTS Import, export, develop, manufacture, and market a broad portfolio of over 100 healthcare products, covering: Ethical Rx, Generics, OTC, Medical devices, Food supplements (VMS), Consumer Health, and advanced Molecular Diagnostics.
201 to 500 staff
Dr. Fischer
The Dr. Fischer Company celebrates more than 55 years of international activity, experience and know-how in the R&D and manufacture of medical preparations and anti-aging cosmeceuticals that help prevent and treat skin aging. These products are manufactured under exacting conditions and quality control according to the most stringent production standards. Dr. Fischer products are successfully marketed worldwide: Europe, America, Asia and the Middle East. תשלובת ד"ר פישר היא קבוצת חברות רב-לאומית והקבוצה המובילה בישראל בתחומה. מעבדות התשלובת פעילות בפיתוח תכשירי הגנה וטיפול בעור ובעיניים, תוך התבססות על טכנולוגיה וידע פרמצבטיים ורפואיים מהמתקדמים בעולם. בתשלובת ד"ר פישר דואגים, כבר למעלה מ- 50 שנה, לפתח את התכשירים המתקדמים ביותר לבריאות כל בני המשפחה, מהריון ועד שיבה טובה, מכף רגל ועד ראש. בשנת 1995 זכו דבורה ז"ל וד"ר אלי פישר, מייסדי תשלובת מפעלי ד"ר פישר, בפרס התעשייה הישראלי, בדיוק 30 שנה לאחר הקמתו של המפעל הראשון בבני ברק. הפילוסופיה שעמדה בבסיס הקמת המפעל היתה מחקר, פיתוח וייצור תרופות עיניים ותכשירים לטיפול בעור. כיום תשלובת מפעלי ד"ר פישר פעילה בישראל ומעבר לים ומעסיקה צוות מקצועי ומיומן של כ- 700 עובדים, ביניהם רוקחים, מיקרוביולוגים, כימאים, ביוכימאים, טכנולוגי מזון, מהנדסי תעשייה וניהול ואנשי שיווק וניהול. מדי חודש מייצרת התשלובת מיליוני יחידות של מוצרים שונים, ביניהם מוצרי טיפול בעור, תרופות מרשם ומוצרי OTC (תרופות ללא מרשם רופא), כגון טיפות עיניים ומוצרי היגיינה. מלבד המוצרים הנמכרים בישראל, משווקת התשלובת את תכשיריה לכ- 30 מדינות ברחבי העולם. מוצרי תשלובת ד"ר פישר נהנים ממוניטין בינלאומיים וזוכים לפופולריות רבה הן בארץ והן בעולם. המחויבות הטוטאלית לאיכות המוצרים מעמידה את מוצרי החברה בסטנדרט הגבוה ביותר בתחום תרופות העיניים והטיפול בעור. כל מוצרי החברה מיוצרים תחת בקרת איכות קפדנית, על-פי תקני הייצור הבינלאומיים המחמירים, ותוך שימוש במרכיבים המתקדמים, הבטוחים והבדוקים ביותר.
501 to 1000 staff
Lapidot Group
Lapidot Group is one of Israel's top healthcare companies. The group specializes in import, distribution and marketing of a variety of health solutions, products and health and wellness services. The company represents leading international companies in their field, carefully chosen for their innovation and scientific excellence. Since its foundation, the group has enjoyed the reputation of a leading and visionary company, demonstrating impressive growth and expansion rates. In 2017, the company was ranked sixth in Dun's 100’s rankings of wholesale medical equipment and medicines in Israel. Our mission statement: Providing Israeli public with access to the best healthcare in the world Because everyone deserves to feel better
201 to 500 staff
Rafa Laboratories
Rafa Laboratories, Ltd. is a pharmaceutical company that has been specializing in the manufacture and marketing of medicines in the Israeli market since 1937. The company strives to supply Israeli patients and physicians with state of the art quality medicines and medical devices for the improved treatment of medical conditions and a better quality of life for patients.
201 to 500 staff
Neurim Pharmaceuticals Ltd
Neurim Pharmaceuticals is a neuroscience drug discovery and development company creating drugs for brain restoration & reinforcement, focusing on the central nervous system. With a proven track record of drug development and commercialization, Neurim’s first products, Circadin® and Slenyto®, are already in use in more than 40 countries across 5 continents. Constantly expanding into additional therapeutic areas, the R&D pipeline comprises new products that address insomnia, Alzheimer’s dementia and sleep apnea.
11 to 50 staff
Noon Aesthetics Ltd
NOON Aesthetics develops and manufactures an extensive portfolio of professional skincare products. The company's proprietary Dermshield technology empowers professional skincare providers to deliver highly effective, safe & irritation-free treatments leading to healthy & beautiful skin for all. NOON Aesthetics management team has extensive experience and a deep understanding of skincare market needs. The company-owned factory enables full control over R&D, IP, formulations, manufacturing and QA processes. The company has ongoing collaborations with leading international pharmaceutical companies active in the skincare market with a global distribution network in over 40 countries.
11 to 50 staff
Panaxia Pharmaceutical Industries
Panaxia is a pharmaceutical company specializing in medical cannabis R&D and manufacturing. We are bringing scientific rigor and pharmaceutical manufacturing standards to the rapidly evolving field of medical cannabis. As a leader in this category, Panaxia is spearheading the adoption of cannabis-based treatments by developing consistent, effective, high-quality products that can be taken through a variety of familiar delivery methods to substantially improve the lives of people with a wide range of medical conditions. We offer over 65 different products, all manufactured under extremely stringent Good Manufacturing Practice (GMP) guidelines and with the most advanced analytical and validation methods to meet the most demanding requirements for consistency and dosage accuracy. Panaxia is part of a group of leading Israeli pharmaceutical companies with more than four decades of experience and proven success. We invest substantially in research and development and have clinical partnerships with prominent medical centers. Operating around the globe, our network is extensive and ever growing. Collaborating with the world’s best medical cannabis companies and organizations enables us to bring cannabis products of the highest quality and consistency to as many people as possible.
51 to 200 staff
Nextar Chempharma Solutions Ltd
Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that develops and manufactures innovative pharmaceuticals and medical devices. The company has helped bring over 180 products to market, both as a contract development and manufacturing organization (CDMO) and for its own portfolio. Nextar has manufacturing capabilities for small-scale sterile and non-sterile products, and its facilities are fully certified and some of the drug products we helped to develop are commercialized globally. Nextar is also developing a proprietary Brain-Transported Liposomes (BTLs) platform, which can deliver generic and innovative drugs across the blood-brain barrier into the brain. This platform has the potential to revolutionize the treatment of brain diseases, such as brain cancer and Parkinson's. Nextar's first product based on the BTLs platform is currently in development for the treatment of glioblastoma. In other words, Nextar is a cutting-edge biotechnology company that is developing innovative new treatments for brain diseases. The company's BTLs platform has the potential to revolutionize the way we treat brain-related diseases.
11 to 50 staff
Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals (NASDAQ:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in Phase 3 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes. Watch: Terms and conditions and privacy policy:
11 to 50 staff
Innocan Pharma
InnoCan Pharma is a pharmaceutical company specializing in developing novel therapeutics that harness the unique healing properties of Cannabinoids to improve quality of life. OUR ADVANTAGES Led by a highly-experienced team with a proven track record of success, InnoCan will leverage Israel’s worldleading medical cannabis research community to develop powerful, Cannabinoid-combined, patent-pending formulas. Our outstanding products will be clinically validated by undertaking Post Marketing Surveillance (PMS) studies and combine smart delivery systems to enhance the potency and efficacy of current products for better results. EXPECTED EARLY REVENUES: InnoCan expects to generate early revenues ($30 million in 5 years) from the multi-billion dollar Over The Counter (OTC) market by leveraging the rapid FDA OTC drug monograph process or similar regulatory pathways in Europe and Canada. These regulatory pathways enable InnoCan, in a very short time, to bring to market outstanding new products that combine the huge therapeutic potential of Cannabinoid complex/hemp oil added “excipients” to existing approved OTC drugs. TECHNOLOGY: POWERFUL, PATENT PENDING FORMULAS WITH SMART DELIVERY SYSTEMS InnoCan's products will be highly differentiated within the market through the powerful synergistic effect of the Cannabis-complex Hemp Oil with the active ingredients, combined with our on-demand release delivery system providing improved patient efficacy and compliance. FIRST-LINE PRODUCTS: A LEAP-FORWARD IN DERMATOLOGY TREATMENT DESIGN The companies first products will initially target the multi-billion dollars markets of psoriasis and localized pain, where research shows topical cannabinoid-combined treatments are highly effective, followed by oral hygiene, eczema/ itching, skin support after chemotherapy and women's health. To join the investment opportunity with InnoCan, please contact Iris Bincovich at IrisB@InnocanPharma.com.
1 to 10 staff
Lts Device Technologies
We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Micro Array Patches (“MAP”) for the transdermal delivery of large molecule, biological actives. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. Founded in 1984, LTS operates today from four sites: in Andernach, Germany, West Caldwell, NJ, USA, St. Paul, MN, USA and Netanya, Israel. LTS has also a representative office in Shanghai, China.
51 to 200 staff
Mapi Pharma
Mapi Pharma is a late clinical stage pharmaceutical company, currently in the final stage of the Phase with its lead product, GA Depot, a long-acting depot glatiramer acetate for treating MS and has several generic commercialized products. Mapi is engaged in the development of high barrier-to-entry and high added-value life cycle management products that target large markets and high barrier patented generic drugs that include complex API and formulations. The GA Depot injection, administered once every four weeks, is the first in a series of depot long-acting injections in the company’s pipeline. The product is a long-acting version of Copaxone®. Mapi partnered with Mylan/Viatris Inc.(NASDAQ: VTRS) for GA Depot in an agreement under which Mylan was granted an exclusive license to commercialize the GA Depot injection product for relapsing forms of multiple sclerosis. Mapi is also in the midst of a Phase II with GA Depot for PPMS and has a pipeline of long acting depot including GLP-1 for treating diabetes and Parkinson’s disease for which we are looking for strategic partners. Mapi is built on strong chemical and pharmaceutical R&D capabilities focused on long acting depot technologies and combination treatments including loaded exosomes derived from adipose tissue. Mapi is headquartered in Israel, with R&D facilities in Israel, an API production facility in the Neot-Hovav Eco Industrial Park and an aseptic manufacturing and a large scale Fill & Finish facility for injectable Finished Dosage Forms in Jerusalem totaling ft2. Mapi Pharma was founded by Ehud Marom who serves as Chairman & CEO of Mapi Pharma and Stem Cell Medicine.
51 to 200 staff
Redhill Biopharma Ltd
RedHill Biopharma Ltd.(NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases and infectious diseases. RedHill’s U.S. commercial operations, headquartered in Raleigh, NC, include a gastrointestinal-focused sales force promoting several specialty gastrointestinal products in the U.S. RedHill’s pipeline includes several drug candidates in advanced clinical development stages addressing clear medical needs and aiming to relieve suffering and save lives. RedHill’s drugs are largely de-risked and are potentially of lower cost and faster to market than new chemical entities under development. RedHill’s products are based on several technology platforms and address several disease targets, thus providing for risk diversification. RedHill’s experienced management team, board of directors and advisory board, based in Israel, the U.S, Canada and Europe, comes with a successful track record of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise.
51 to 200 staff
Azura Ophthalmics Limited
Azura Ophthalmics is utilizing our deep understanding of ocular surface diseases and drug development to deliver a new therapeutic class of Ophthalmic Keratolytics to treat underserved ophthalmic conditions. Our differentiated approach combines ophthalmologic and dermatologic solutions to harness the unique properties of keratolytics to treat the root cause of numerous underserved ocular indications. Our internally discovered pipeline of new chemical entities allows us to develop a portfolio of first-in-class ophthalmic therapeutics for significant unmet needs.
1 to 10 staff
Im Cannabis Imc - Premium Medical Cannabis
Premium Medical Cannabis Products for Global Consumers – IM Cannabis (IMC) is one of the world's pioneering medical-grade cannabis companies, with operations in Israel, across Europe, and Canada. Over the past decade, IMC has established its premium medical cannabis brand, comprising a full spectrum of products known for their quality, consistency, and purity, such as 'ROMA','TEL AVIV' and 'LONDON'. In Europe, IMC has established a fully operational, vertically integrated medical cannabis business, spearheaded by its EU-GMP certified distribution arm in Germany and augmented by strategic alliances with certified pan-EUGMP certified suppliers. To this end, IMC has formed strong strategic alliances within the international medical cannabis industry, aiming for a dominant position in satisfying the global demand for high-quality medical cannabis products, which both physicians and patients can rely upon. IMC further intends to leverage its expertise in Israel in order to bolster its research and development initiative while collaborating with world-renowned scientists on cutting-edge technology for the benefit of patients around the world To find out about investment opportunities with IMC, please contact [Ben Brownstein] at ben.b@imcannabis.com
201 to 500 staff
Pharma Clinical S.A.G 2003 Ltd
Pharma Clinical S.A.G.(2003) Ltd is an independent Contract Research Organization which has provided services in Israel to local and international pharmaceutical companies since 1988. With more than 30 years of experience, Pharma Clinical has performed more than 200 clinical studies and recruited more than subjects. Our extensive knowledge of clinical trial performance and our professional expertise is derived from our relationships with top academic institutes, medical institutes and scientific facilities throughout the country. We maintain strong long-term relationships with key opinion leaders across a broad range of therapeutic areas, enabling the company to provide fast and reliable feasibility processes and rapid set-up of trials. Participating centers include leading academic units with an international reputation for excellence. Pharma Clinical provides tailored services to assist the sponsor in delivering quality studies most efficiently. Our focus is on cost effective solutions that reduce development cycle timelines and accelerate the delivery of life-enhancing drugs to the market for the benefit of patients worldwide. Our flexibility allows us to provide full service solutions or stand-alone services addressing any specific sponsor needs.
11 to 50 staff
Precise Engineering
Precise Engineering designs, implements and validates sensitive plants and facilities for the Life Sciences industries (pharmaceutical, Biotechnology, Medical Devices), chemical, semiconductors, electronics and defence industries. From conceptual design to a full turnkey solution, Precise Engineering provides multi-disciplinary solutions, integrating extensive regulatory knowledge and vast experience in facility process engineering. סיימת בדיוק עכשיו לימודי הנדסת כימיה באוניברסיטת תל אביב, באר שבע והטכניון בממוצע 85 ומעלה ורוצה להשתלב בתחום Process Engineering הנדסת תהליך? פרסייס הנדסה רוצה אותך! נא לשלוח גיליון ציונים + קורות חיים ל job@precise-eng.com
11 to 50 staff
Truemed Therapeutics
TrueMed is the premier Rare Disease company in Israel. As the local partner of choice for leading global innovators, TrueMed has commercialized some of the most advanced, cutting edge therapies ever developed. We provide tailored, holistic solutions designed to support our patients and their families on their journey, and to optimize outcomes for them and for our partners. TrueMed provides a turnkey solution from early access through registration, reimbursement, distribution, and support services, all based on custom business models for each therapy that we distribute. We develop each model to fit the unique needs of the patients and the requirements of the therapy, including complex administration and challenging adherence. With a clear focus and a passionate team, we deliver a rare dedication to wellness. For additional information: info@truemed.co.il
11 to 50 staff
Dir Technologies
DIR Technologies has disrupted the status quo of quality assurance in the packaging industry by applying technology born in the defense industry to sealing integrity monitoring. Because sampling isn’t enough. DIR solutions oer a quantum leap from commonly used methods of sampling by providing 100% in-line, non-intrusive inspection that does not result in production slowdown. DIR Technologies is leading the way in the use of thermal imaging in the pharmaceutical industry for PAT applications and has led several patents on the subject. Solutions DIR Technologies is the developer and provider of rst-in-industry thermography-based inspection solutions for packaging quality assurance and process control. DIR’s flagship product, the Induction Integrity Verification System (I2VS) is the first system that can provide true process control with 100% sealing integrity monitoring for pharmaceutical primary packaging. The I2VS won the ACHEMA 2015 Innovation Award for best new technology in packaging. DIR Technologies is currently in the process of expanding the company’s product portfolio to include quality assurance and process control solutions for non-pharmaceutical packagers including the I2VS Lite, a stripped down, more modular version of the I2VS and the DIR Eye for heat sealing monitoring. The DIR Eye has numerous applications for packaging in different industries including: food and beverage, cosmetics, chemicals and medical device packaging. DIR solutions are in various stages of sales, pilots and trials with a number of tier one companies around the world. Background The company was established in 2009 by entrepreneurs Eran Sinbar and Yoav Weinstein and is jointly owned by major Israeli defense companies Rafael Advanced Defense Systems, LTD, Elbit Systems and the Israeli-American fund SCP Vitalife. DIR Technologies is a spin-o of SCD – SemiConductor Devices, one of the largest manufacturers of advanced Infrared sensors worldwide.
11 to 50 staff
Intercure
InterCure (dba Canndoc)(NASDAQ: INCR)(TSX: INCR.U)(TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America. For more information, visit:
201 to 500 staff
Msd Animal Health Israel
MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals through science. We offer veterinarians, farmers, pet owners and governments the widest range of veterinary pharmaceuticals, parasiticides, vaccines and health management solutions. MSD Animal Health, is the global animal health business unit of MSD.
11 to 50 staff
Omnix Medical
Omnix Medical is a clinical company, dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains, a highly common problem in today's medicine especially in chronic conditions and in modern hospitals. These agents are based on natural antimicrobial peptides, genetically engineered to be compatible for therapeutic use. Omnix is addressing an enormous and rapidly growing market opportunity, represented by millions of Americans and many more millions worldwide, who suffer from infections associated with resistant bacteria.
11 to 50 staff
Painreform Ltd
PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory pathway, PainReform applies unique technologies to enhance efficacy, reduce adverse effects and increase convenience. Our mission is to offer pain therapeutics with clinically meaningful benefits to both physicians and patients.
1 to 10 staff
Patho-Logica Experimental Pathology Services Laboratory
Patho-Logica provides services in the field of pathology and related scientific services. We support scientists, investogators and physicians during the pre-clinical and clinical phase of their drug/device product development. We specialize in the field of experimental pathology and our major expertise are efficacy studies as well as the exposure of the mechanism of action. We believe that skillful and accurate interpretation of histology and pathology specimens is critical to consistent success in efficacy, pharmacology, and toxicology studies. Among our services- High standard pathological evaluation of your animal study - Wide range of technical approaches for light and fluorescent microscopy: frozen sections, free floating sections, paraffin embedded sections, plastic embedding - Morphometry quantitative approaches; special double blinded method for your histological database using advance knowledge and technology - State-of-the-art technological microscopy providing high quality of histological pictures
1 to 10 staff
